Transdermal oxybutynin: topical therapy for overactive bladder syndrome

By Wagg Adrian  

Expert Review of Obstretrics and Gynecology, Vol. 3, Iss. 2, 2008-03 ,pp. : 175-179

Informa Healthcare

Access to resources Recommend Favorite

Tolterodine reduces the number of urge incontinence episodes in patients with an overactive bladder

By Jacquetin B.   Wyndaele J.-J.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 98, Iss. 1, 2001-09 ,pp. : 97-102

Elsevier

Access to resources Recommend Favorite

Reduced perception of urgency in treatmentof overactive bladder with extended-release tolterodine

By Freeman R.   Hill S.   Millard R.   Slack M.   Sutherst J.   Tolterodine Study Group  

Obstetrics and Gynecology, Vol. 102, Iss. 3, 2003-09 ,pp. : 605-611

Elsevier

Access to resources Recommend Favorite

Treatment of overactive bladder (OBA) with anti-cholinergic drugs and the risk of glaucoma

By Eskandar O. S.   Eckford S. D.   Whittaker K. W.  

Journal of Obstetrics & Gynaecology, Vol. 25, Iss. 5, 2005-07 ,pp. : 419-421

Informa Healthcare

Access to resources Recommend Favorite

Retropubic urethrolysis of colposuspension: Does it improve voiding and overactive bladder symptoms?

By Basu M.   Duckett J. R. A.   Papanikolaou N.  

Journal of Obstetrics & Gynaecology, Vol. 28, Iss. 8, 2008-11 ,pp. : 783-786

Informa Healthcare

Access to resources Recommend Favorite